In hepatocellular carcinoma, cancer stem cells lacking THBS2 promote tumor invasiveness and drug resistance by regulating matrix metalloproteinase (MMP) activity and matrix stiffness [36]. The gene discussed is THBS2; the disease is hepatocellular carcinoma.